Conference Reports

Singapore
17 November 2017 - 19 November 2017
Denver, Colorado,
29 October 2017 - 02 November 2017
Singapore
06 October 2017 - 08 October 2017
Milan, Italy
09 September 2017 - 13 September 2017
Singapore
13 July 2017 - 15 July 2017
San Diego, California, US
09 June 2017 - 13 June 2017
Chicago, Illinois, US
02 June 2017 - 06 June 2017
Washington, DC
19 May 2017 - 24 May 2017
Geneva
05 May 2017 - 08 May 2017
Houston, Texas, US
22 February 2017 - 24 February 2017
Amsterdam
27 January 2017 - 30 January 2017
San Diego, California
03 December 2016 - 06 December 2016
San Antonio, Texas
06 December 2016 - 10 December 2016
Vienna
04 December 2016 - 07 December 2016
12 November 2016 - 16 November 2016
Singapore
20 July 2016 - 24 July 2016
New Orleans, Louisiana
10 June 2016 - 14 June 2016
Geneva
13 April 2016 - 16 April 2016
San Antonio, Texas, US
08 December 2015 - 12 December 2015
Orlando, Florida, US
05 December 2015 - 08 December 2015
London
29 August 2015 - 02 September 2015
Bali
22 November 2014 - 25 November 2014
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elaine Soliven, 27 Sep 2017
A second dose of kisspeptin-54 improves oocyte yield in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) treatment, according to a recent study.
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Rachel Soon, 2 days ago

Pharmacists can and should utilize their positions within communities to provide access to an extended range of healthcare services, says an expert.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.